News on Taxol from BioPortfolio.com http://www.BioPortfolio.com Consolidated Taxol news from BioPortfolio.com Wed, 10 Feb 2010 14:46:23 GMT en Genta commences Phase 2 trial of tesetaxel on first subjecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=0&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=0&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Genta commences treatment in tesetaxel Phase 2 trial for advanced melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=1&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=1&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=2&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=2&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=3&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=3&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=4&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=4&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=5&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=5&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=6&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=6&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=7&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=7&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: EU clears Eurocor's coronary stenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002547&HITNO=8&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002547&THISHREF=http://c.moreover.com/click/here.pl%3fz2519046401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002547&HITNO=8&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002547&THISHREF=http://c.moreover.com/click/here.pl%3fz2519046401%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCardiovascular Business: Children's Hospital Boston Researchers ID Protein That May Explain Paclitaxel Resistancehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995046&HITNO=9&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995046&THISHREF=http://c.moreover.com/click/here.pl%3fz2515437509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995046&HITNO=9&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995046&THISHREF=http://c.moreover.com/click/here.pl%3fz2515437509%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: Overcoming Taxane Resistance in Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984033&HITNO=10&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984033&THISHREF=http://c.moreover.com/click/here.pl%3fz2507994465%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984033&HITNO=10&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984033&THISHREF=http://c.moreover.com/click/here.pl%3fz2507994465%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984623&HITNO=11&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984623&THISHREF=http://c.moreover.com/click/here.pl%3fz2508243130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984623&HITNO=11&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984623&THISHREF=http://c.moreover.com/click/here.pl%3fz2508243130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Protein may Help Overcome Taxane Resistance in Cancer Drugs: Discoveryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974487&HITNO=12&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974487&THISHREF=http://c.moreover.com/click/here.pl%3fz2503540291%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974487&HITNO=12&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974487&THISHREF=http://c.moreover.com/click/here.pl%3fz2503540291%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedIndia: Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975609&HITNO=13&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975609&THISHREF=http://c.moreover.com/click/here.pl%3fz2504110744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975609&HITNO=13&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975609&THISHREF=http://c.moreover.com/click/here.pl%3fz2504110744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Medical News: Proteomics Study Reveals A Protein That, When Suppressed, Makes Cancers More Susceptible To Chemotherapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975295&HITNO=14&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975295&THISHREF=http://c.moreover.com/click/here.pl%3fz2503986241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975295&HITNO=14&MSIZE=89&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Taxol&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975295&THISHREF=http://c.moreover.com/click/here.pl%3fz2503986241%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: